• Former CEO of Merck Generics Group
• Over 30 years of healthcare experience with global multinationals such as Genpharm, Merck and Mylan
• Joined Merck KgaA (previously Genpharm) in 2001 and was appointed Chief Executive Officer in 2003, where he was responsible for Merck’s global business as well as the development of Merck’s generic businesses in North, Central and South America

Education:

• B.S. from University of Toronto’s Erindale College